CN1281211C - 噁唑烷酮类物质在制备治疗哺乳动物眼部感染的药物中的用途 - Google Patents

噁唑烷酮类物质在制备治疗哺乳动物眼部感染的药物中的用途 Download PDF

Info

Publication number
CN1281211C
CN1281211C CNB028154673A CN02815467A CN1281211C CN 1281211 C CN1281211 C CN 1281211C CN B028154673 A CNB028154673 A CN B028154673A CN 02815467 A CN02815467 A CN 02815467A CN 1281211 C CN1281211 C CN 1281211C
Authority
CN
China
Prior art keywords
formula
chemical compound
mixture
purposes
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028154673A
Other languages
English (en)
Chinese (zh)
Other versions
CN1545428A (zh
Inventor
J·G·斯拉特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn Co filed Critical Pharmacia and Upjohn Co
Publication of CN1545428A publication Critical patent/CN1545428A/zh
Application granted granted Critical
Publication of CN1281211C publication Critical patent/CN1281211C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CNB028154673A 2001-09-14 2002-09-11 噁唑烷酮类物质在制备治疗哺乳动物眼部感染的药物中的用途 Expired - Fee Related CN1281211C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32215301P 2001-09-14 2001-09-14
US32211501P 2001-09-14 2001-09-14
US60/322,153 2001-09-14
US60/322,115 2001-09-14

Publications (2)

Publication Number Publication Date
CN1545428A CN1545428A (zh) 2004-11-10
CN1281211C true CN1281211C (zh) 2006-10-25

Family

ID=26983274

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028154673A Expired - Fee Related CN1281211C (zh) 2001-09-14 2002-09-11 噁唑烷酮类物质在制备治疗哺乳动物眼部感染的药物中的用途

Country Status (12)

Country Link
US (2) US20030069235A1 (https=)
EP (1) EP1425068A1 (https=)
JP (1) JP2005507884A (https=)
KR (1) KR20040035769A (https=)
CN (1) CN1281211C (https=)
BR (1) BR0212466A (https=)
CA (1) CA2460360A1 (https=)
IL (1) IL160490A0 (https=)
MX (1) MXPA04002071A (https=)
NZ (1) NZ531353A (https=)
PL (1) PL370033A1 (https=)
WO (1) WO2003024528A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108283622A (zh) * 2018-04-03 2018-07-17 广州君博医药科技有限公司 一种缓释型利奈唑胺眼用药物及其制备方法
WO2021184339A1 (en) 2020-03-20 2021-09-23 Merck Sharp & Dohme Corp. Oxazolidinone compound and methods of use thereof as an antibacterial agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
CN1305374A (zh) * 1998-07-14 2001-07-25 法玛西雅厄普约翰美国公司 治疗眼部感染的噁唑烷酮
ATE337002T1 (de) * 1999-09-13 2006-09-15 Insite Vision Inc Topische behandlung zur vorbeugung von augeninfektionen
US6696426B2 (en) * 2000-08-22 2004-02-24 Pharmacia Corporation Preservative free ophthalmic oxazolidinone antibiotic drug delivery systems
PE20020578A1 (es) * 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares

Also Published As

Publication number Publication date
WO2003024528A1 (en) 2003-03-27
US20030069235A1 (en) 2003-04-10
CA2460360A1 (en) 2003-03-27
IL160490A0 (en) 2004-07-25
MXPA04002071A (es) 2005-02-17
KR20040035769A (ko) 2004-04-29
NZ531353A (en) 2006-09-29
CN1545428A (zh) 2004-11-10
US20050234052A1 (en) 2005-10-20
HK1068564A1 (en) 2005-04-29
EP1425068A1 (en) 2004-06-09
PL370033A1 (en) 2005-05-16
BR0212466A (pt) 2004-10-19
JP2005507884A (ja) 2005-03-24

Similar Documents

Publication Publication Date Title
RU2481842C2 (ru) Низковязкие высокофлокулированные суспензии триамцинолона ацетонида для интравитреальных инъекций
Gimbel et al. Prophylactic intracameral antibiotics during cataract surgery: the incidence of endophthalmitis and corneal endothelial cell loss
US10993921B2 (en) Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
US10285957B2 (en) Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
US20250170151A1 (en) Low-sorbing glyburide kit, formulation and methods
US20190105320A1 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20230302032A1 (en) Antibacterial compositions and methods for fabricating thereof
JP3502574B2 (ja) 眼感染症治療用眼軟膏剤
CN1281211C (zh) 噁唑烷酮类物质在制备治疗哺乳动物眼部感染的药物中的用途
JPS63166832A (ja) 鼻用溶液
KR20010072228A (ko) 위장 독성이 감소된 캠프토테신 유도체의 용도
JP2021514393A (ja) 複数回使用のトラセミド組成物
US20020183279A1 (en) Pharmaceutical composition containing viscoelastic substance and medication
HUT71250A (en) Remedy for cataract and production thereof
US20240058320A1 (en) Mydriatic compositions and methods for fabricating thereof
EP1863481A1 (en) Methods for administering ixabepilone
JPH0477434A (ja) 顆粒球コロニー刺激因子の眼粘膜適用製剤
US20250134849A1 (en) Pharmaceutical composition for preventing or treating ocular disease comprising enavogliflozin
AU2002341559A1 (en) Systematical administration of some oxazolidinones, e.g. linezolid, for the treatment for ocular infections
CN1870974B (zh) 注射用加巴喷丁组合物的生产方法
ZA200401995B (en) Treatment for ocular infections.
HK1068564B (en) The use of oxazolidones substance in the preparation of a medicament for treating ophthalmic infection in mammal
WO2020117497A1 (en) Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
CN101366701A (zh) N，n-二甲基甘氨酸-2，6-二异丙基苯酯盐类注射剂
MXPA94003569A (en) Stable quinolone and naphthyridine premix formulations

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1068564

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee